bioRxiv / medRxiv
open access
CC BY 4.0
Application of nucleoside analogue labelling to study the cell cycle of xenografted PDAC cell lines in the chorioallantoic membrane model.
The chorioallantoic membrane (CAM) model is an underutilised alternative model for the research into tumour xenografts. We demonstrate that in the pancreatic cancer cell lines BxPC-3 and AsPC-1, nucleoside labelling with 5-ethynyl-2'-deoxyuridine (EdU) can be multiplexed with other human cell cycle
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Efficacy and Safety of 'Immuncell-LC Group' and 'Non-treatment Group' in Nexavar Treated Patients for Advanced HCC#1089033
- Potential Therapeutic Response In Urogenital Tumors#1261550
- Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil for Advanced Cholangiocarcinoma#1103486
- Estudio piloto de las nuevas guías de tamizaje molecular para el cáncer de cuello uterino: análisis retrospectivo de una cohorte de pacientes colombianas#406731
- Phase 1 In-vivo Biliary Study of KSP/QRH Heptapeptide Dimer#857767
Record · ID 1181750
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive